| Record Information |
| Version |
3.5 |
| Creation Date |
2006-05-18 02:31:29 -0600 |
| Update Date |
2013-02-08 17:11:01 -0700 |
| HMDB ID |
HMDB01922 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Clotrimazole |
| Description |
Clotrimazole is an imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. -- Pubchem; There is the potential for drug interactions with Clotrimazole if taken orally, as it is a potent, specific inhibitor of cytochrome P450 oxidase enzymes and so may alter the metabolism of other drugs. Clotrimazole is an antifungal medication commonly used in the treatment of fungal infections of both humans and animals such as vaginal yeast infections and ringworm. -- Wikipedia; An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. Clotrimazole is a potent, specific inhibitor of cytochrome P450 oxidase enzymes. Hence, it may alter the metabolism of other drugs particularly if taken orally. -- Wikipedia; Clotrimazole is an antifungal medication commonly used in the treatment of fungal infections of both humans and animals such as vaginal yeast infections and ringworm. It also used to treat athlete's foot and jock itch. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (Chlorotrityl)imidazole
- 1-(O-Chlorotrityl)imidazole
- Canesten
- Canesten 1-Day Cream Combi-Pak
- Canesten 1-Day Therapy
- Canesten 3-Day Therapy
- Canesten 6-Day Therapy
- Canesten Combi-Pak 1-Day Therapy
- Canesten Combi-Pak 3-Day Therapy
- Canesten Cream
- Canesten Solution
- Canestine
- Chlotrimazole
- Clotrimaderm
- Clotrimaderm Cream
- Clotrimazol
- Clotrimazole
- Clotrimazolum
- Desamix F
- Empecid
- Fem Care
- FemCare
- Gyne lotrimin
- Gyne-lotrimin
- Gyne-Lotrimin 3
- Gyne-Lotrimin 3 Combination Pack
- Gyne-Lotrimin Combination Pack
- Gyne-Lotrimin3
- Gyne-Lotrimin3 Combination Pack
- Gynix
- Lopac-C-6019
- Lotrimax
- Lotrimin
- Lotrimin AF
- Lotrimin AF Cream
- Lotrimin AF Jock-Itch Cream
- Lotrimin AF Lotion
- Lotrimin AF Solution
- Lotrimin Cream
- Lotrimin Lotion
- Lotrimin Solution
- Lotrisone
- Mono-baycuten
- Monobaycuten
- Mycelax
- Mycelex
- Mycelex 7
- Mycelex Cream
- Mycelex G
- Mycelex OTC
- Mycelex Solution
- Mycelex Troches
- Mycelex Twin Pack
- Mycelex-7
- Mycelex-7 Combination Pack
- Mycelex-G
- Mycelex: MycosporinRimazole
- Myclo Cream
- Myclo Solution
- Myclo Spray Solution
- Myclo-Gyne
- Mycosporin
- Mykosporin
- Neo-Zol Cream
- Otomax
- Pedisafe
- Prestwick_120
- Rimazole
- Tibatin
- Trimysten
- Trivagizole 3
- Veltrim
|
| Chemical Formula |
C22H17ClN2 |
| Average Molecular Weight |
344.837 |
| Monoisotopic Molecular Weight |
344.108026261 |
| IUPAC Name |
1-[(2-chlorophenyl)diphenylmethyl]-1H-imidazole |
| Traditional IUPAC Name |
clotrimazole |
| CAS Registry Number |
23593-75-1 |
| SMILES |
ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1 |
| InChI Identifier |
InChI=1S/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H |
| InChI Key |
VNFPBHJOKIVQEB-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aromatic Heteropolycyclic Compounds |
| Class |
Diphenylmethanes |
| Sub Class |
N/A |
| Other Descriptors |
- Aromatic Heteropolycyclic Compounds
- a small molecule(Cyc)
- imidazoles(ChEBI)
- organochlorine compound(ChEBI)
|
| Substituents |
- Aryl Chloride
- Chlorobenzene
- Imidazole
- Organochloride
- Phenylmethylamine
|
| Direct Parent |
Diphenylmethanes |
| Ontology |
| Status |
Expected and Not Quantified |
| Origin |
|
| Biofunction |
Not Available |
| Application |
Not Available |
| Cellular locations |
- Membrane (predicted from logP)
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
148 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
- Membrane (predicted from logP)
|
| Biofluid Locations |
Not Available
|
| Tissue Location |
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
Not Available |
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB022740 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
2710  |
| KEGG Compound ID |
C06922  |
| BioCyc ID |
Not Available |
| BiGG ID |
Not Available |
| Wikipedia Link |
Clotrimazole  |
| NuGOwiki Link |
HMDB01922  |
| Metagene Link |
HMDB01922  |
| METLIN ID |
1897  |
| PubChem Compound |
2812  |
| PDB ID |
CL6  |
| ChEBI ID |
3764  |
| References |
| Synthesis Reference |
Not Available |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Lucker PW, Beubler E, Kukovetz WR, Ritter W: Retention time and concentration in human skin of bifonazole and clotrimazole. Dermatologica. 1984;169 Suppl 1:51-5.
Pubmed: 6526092
- Schmidt A, Ruhl-Horster B: In vitro susceptibility of Malassezia furfur against azole compounds. Mycoses. 1996 Jul-Aug;39(7-8):309-12.
Pubmed: 9009652
- Schmook FP, Meingassner JG, Billich A: Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm. 2001 Mar 14;215(1-2):51-6.
Pubmed: 11250091
|
| Enzymes |
|
|
|
|
|
|
| Name: |
Cytochrome P450 2D6
|
| Reactions: |
- RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O [RN:R04122]
|
| Gene Name: |
CYP2D6 |
| Uniprot ID: |
P10635  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
| Name: |
Cytochrome P450 1A2
|
| Reactions: |
- RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O [RN:R04122]
|
| Gene Name: |
CYP1A2 |
| Uniprot ID: |
P05177  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|